Progressive Supranuclear Palsy (PSP): Symptoms and Care

Armchair and notebook in a calm room with an abstract network of lights, a conceptual illustration of coordinated PSP care

Neurology · Educational guide

Progressive supranuclear palsy (PSP) is a rare, progressive brain condition that can affect balance, walking, eye movements, speech, swallowing, thinking, and behavior. Its first signs do not look the same in everyone, and diagnosis may take time. This guide explains what PSP is, how specialists assess it, and how treatment and practical support can help with everyday life. It is general education for learners, people seeking reliable background, and families; it cannot establish a diagnosis or replace an individual care plan. [2]

Educational content · Sources checked October 6, 2026

Understanding progressive supranuclear palsy

PSP belongs to a group of conditions called atypical parkinsonian disorders. Parkinsonism describes a pattern that can include slow movement and stiffness; it does not identify a single disease. PSP has its own underlying brain changes and clinical patterns. Recognizing that distinction matters because the expected response to medication, priorities for rehabilitation, and information families need can differ from those for Parkinson disease. [1]

The name describes several features of the condition. Progressive means that difficulties generally increase over time. Supranuclear refers to damage in brain pathways that control certain movements, especially eye movements, above the nerve centers that directly operate the muscles. Palsy describes impaired movement. These terms explain the name but do not capture the whole experience: communication, judgment, fatigue, and everyday participation can also be affected. [1]

PSP usually begins in middle or later adulthood, most often after age 60. It is uncommon, and early symptoms overlap with several more familiar conditions. A person who starts falling, taking longer to complete tasks, or struggling to read does not necessarily have PSP. Those changes deserve clinical assessment in their own right. A careful history and examination help distinguish a progressive neurological pattern from other possible explanations. [2]

Tau, brain changes, and what causes PSP

Tau is a protein normally present in the nervous system. Among its functions, it helps support microtubules, structures involved in a cell’s shape and internal transport. In PSP, abnormal tau accumulates in brain cells, including nerve cells and supporting cells. PSP is therefore described as a tauopathy. The areas affected help explain why a single condition can change movement, eye control, speech, and aspects of thinking. [6]

Understanding the role of tau is different from knowing why a particular person develops PSP. Researchers are investigating genetic susceptibility, how tau changes and accumulates, and other biological or environmental influences. There is no established single trigger that explains most cases. The disease should not be attributed to a person’s attitude, a routine dietary choice, or a failure to exercise. Unproven explanations can create blame without improving care. [1, 13]

Several brain diseases involve abnormal tau, but they are not interchangeable. The form of the protein, the cells involved, and the distribution of damage differ between disorders. A news report about a tau treatment for another condition does not establish that it will help PSP. Evidence must address the relevant disease, the treatment’s effects in people, and meaningful outcomes such as function or quality of life. [7, 20]

For general biology background, Sly Academy’s guide to nucleic acids explains how genetic information relates to proteins. The biology flashcards offer broader study practice. These are general educational resources, rather than clinical guides to PSP or tools for interpreting a genetic test.

Symptoms and the different patterns of PSP

PSP does not always begin with the complete combination of symptoms described in textbooks. One person may first have unexplained falls; another may develop stiffness and slowness, changes in speech, or difficulties planning actions. Symptoms can become clearer as time passes. This variation is one reason clinicians may initially use a broader diagnosis and later refine it after repeat examinations and a more complete history. [7]

The classic pattern, often called PSP–Richardson syndrome, commonly combines early balance problems or falls with abnormalities of vertical eye movement. Other recognized presentations can initially emphasize parkinsonism, freezing of gait, speech and language problems, or frontal cognitive and behavioral changes. Some people have features of a corticobasal syndrome. These names describe patterns observed by specialists; they are not a checklist for choosing a diagnosis at home. [7, 22]

A variant label can help organize observations and explain why two people with PSP seem different. It does not create a fixed timetable or a guarantee about later symptoms. Clinical features can overlap and evolve. Descriptions such as possible or probable PSP communicate diagnostic confidence under clinical criteria, rather than how seriously a person’s symptoms should be taken or how much support they deserve. [7]

The same caution applies to descriptions of early, middle, or advanced PSP. Such language can communicate increasing support needs, but boundaries are not precise. Walking, swallowing, speech, and thinking do not necessarily change together. A person may need substantial help in one area while retaining useful abilities in another. Planning around actual function is more informative than assigning a stage and assuming that every feature associated with it must follow. [3, 17]

Movement, balance, and falls

Walking may become slower, less steady, or difficult to start. Some people describe their feet as seeming stuck, particularly when turning or moving through a doorway. Stiffness can affect the neck and trunk as well as the limbs. Problems adjusting posture and recovering balance can make a small disruption dangerous. Falls, including backward falls, may happen relatively early in the classic PSP pattern. [3, 22]

Several difficulties can contribute to the same fall. Restricted downward gaze can make obstacles harder to notice; turning can challenge balance; and impulsive movement can outpace physical ability. A person may stand up quickly despite needing help. Interpreting this only as carelessness misses the neurological context. Useful assessment considers what happened before the fall, the environment, footwear, transfers, attention, and the support available at that moment. [8, 10]

Progressive movement problems can affect dressing, getting into bed, bathing, and using the toilet long before someone describes themselves as unable to walk. A practical review therefore looks beyond distance walked. The effort, time, safety, and assistance required for ordinary activities matter. Equipment and support should be reconsidered when needs change, including after near falls, rather than waiting for a serious injury to demonstrate that the previous plan is insufficient. [26]

Eye movements and visual difficulties

PSP can slow the rapid eye movements used to shift attention between targets and can limit voluntary gaze, particularly up and down. These problems concern the brain’s control of eye movement; ordinary changes to a glasses prescription may not resolve them. Someone may struggle to scan a page, look down at food, judge a step, or locate an object despite being able to see it clearly once it is in view. [8, 22]

Eyelid problems can add another layer of difficulty. Reduced blinking may contribute to dry or uncomfortable eyes. Some people experience involuntary eyelid closure or difficulty initiating eyelid opening. Light sensitivity and blurred or double vision may also occur. An assessment can distinguish these problems from common, treatable eye conditions that happen alongside PSP. The presence of a neurological diagnosis should not make every new visual symptom automatically attributable to it. [13]

Practical adaptations may include changing the position of reading material, improving contrast and lighting, or reducing visual clutter. The best arrangement depends on gaze control, posture, comfort, and the activity itself. An eye specialist and occupational therapist can help assess options; selected eyelid symptoms may have specific treatments. Visual impairment also affects mobility, so recommendations work best when they are shared with the wider care team. [8, 22]

Speech, swallowing, thinking, and behavior

Communication and swallowing

Speech may become slower, quieter, strained, or less distinct. Some people have difficulty coordinating the movements required for speech, while others also experience language problems. These are different issues and may need different communication approaches. A delayed or unclear response does not reveal how much someone understands. Allowing enough time, reducing background noise, and checking meaning can help preserve a person’s role in everyday conversations and decisions. [5, 17]

Swallowing difficulties, called dysphagia, can affect eating, drinking, and taking medicines. Warning signs can include coughing during meals, a wet or gurgly voice after swallowing, food remaining in the mouth, prolonged meals, or weight loss. Food, drink, or saliva can pass below the vocal cords into the windpipe; this is called aspiration. Aspiration can sometimes occur without obvious coughing, so the absence of a dramatic choking episode does not establish that swallowing is safe. [8, 9, 28]

Thinking, mood, and other symptoms

Changes in thinking often involve attention, planning, mental flexibility, and the ability to begin or organize an activity. Apathy can make it difficult to start something even when the person previously enjoyed it. Impulsivity can undermine safety awareness. These features may be mistaken for stubbornness or lack of interest in family life. Recognizing a possible neurological contribution can lead to more useful support and less conflict. [3, 17]

Emotional changes also deserve attention. Depression, anxiety, or episodes of crying or laughing that do not match the situation can occur. A fixed facial expression or slowed speech should not be taken as a reliable account of a person’s feelings. Assessment should consider mood, communication barriers, discomfort, sleep, and the pressures of living with disability. Changes in behavior can affect relationships while still warranting a compassionate and clinically informed response. [1, 13]

Other difficulties, including sleep disruption, constipation, or bladder symptoms, can add substantially to the daily burden. They deserve assessment even when falls and movement attract more attention. A familiar diagnosis does not exclude common conditions, medication effects, or a separate treatable problem. Describing when symptoms occur and how they affect rest, meals, mobility, or personal care helps the team see their practical importance and decide what needs investigation. [3, 22]

How PSP differs from Parkinson disease

PSP and Parkinson disease can both produce stiffness and slow movement, which explains some early diagnostic confusion. The overall pattern is more informative than one shared symptom. Early recurrent falls, prominent difficulty looking vertically, and early speech or swallowing problems can raise suspicion of PSP. A resting tremor is less typical of PSP, but its presence or absence alone cannot reliably separate the two conditions. [22, 29]

Many people with Parkinson disease have a sustained improvement in movement symptoms with levodopa. In PSP, a trial may produce little benefit, although some people, particularly those with a parkinsonian presentation, have an initial or partial response. Medication response is one piece of the assessment, not a diagnostic verdict. A clinical team considers the symptom history, examination, progression, and other possible causes together. [8, 14]

The comparison below describes tendencies rather than universal rules. It cannot be used to diagnose either condition or predict an individual’s course. There are other causes of parkinsonism, including multiple system atrophy, corticobasal disorders, medication effects, and vascular or structural brain changes. When the clinical picture is uncertain, reassessment by a neurologist with movement-disorder expertise may be more useful than trying to force every symptom into a familiar label. [22, 29]

Common clinical tendencies, not diagnostic rules
FeaturePSPParkinson disease
Balance and fallsMay be prominent early, especially in Richardson syndromeOften become prominent later in the course
Vertical eye movementsSlowing or limitation can be a key featureA marked vertical gaze palsy is not typical
Resting tremorLess typical, although tremor can occurCommon, but absent in some people
Levodopa responseOften limited; some presentations show partial or initial benefitOften a clearer and more sustained benefit for movement symptoms
AssessmentRequires the overall history, neurological examination, and consideration of alternatives

On smaller screens, scroll the table sideways. These are broad patterns with important exceptions. [22, 29]

How specialists diagnose PSP

Diagnosis begins with a detailed account of changes over time. Clinicians ask about falls, walking, eye movement, speech, swallowing, daily function, and changes in thinking or behavior. They may also ask about medicines and other illnesses that could contribute to the symptoms. With the person’s agreement, observations from someone who knows them well can add useful detail, particularly when gradual changes have been difficult to recognize. [4]

The neurological examination brings those observations together. A specialist may assess the speed and range of eye movements, posture, muscle stiffness, walking, balance, speech, and cognitive function. Not every feature is present at the first appointment. Diagnostic criteria help clinicians identify combinations that support PSP, consider alternative explanations, and describe their level of certainty. They support specialist judgment rather than replacing a full clinical assessment. [4, 7]

Uncertainty can be frustrating, especially when practical problems are already substantial. A changing diagnosis does not necessarily mean that an earlier assessment was careless: some disorders become distinguishable only as their pattern develops. It is useful to understand what currently supports the diagnosis, what remains uncertain, and what would prompt reconsideration. Rehabilitation, falls assessment, swallowing evaluation, and communication support can address identified needs during that process. [4]

Preparation can make a specialist appointment more useful. A concise timeline of the first changes, examples of falls or freezing, an up-to-date medicine list, and the most pressing daily difficulties give the discussion a clear starting point. It is also worth distinguishing symptoms the person reports from changes someone else has observed. Questions about referrals, follow-up, and whom to contact between appointments help turn an assessment into an understandable care plan. [14]

What brain scans and other tests can show

There is no single routine blood test or scan that conclusively establishes PSP in a living person. MRI can help identify structural explanations for symptoms and may show patterns that support a suspected diagnosis. Changes involving the midbrain are sometimes described using visual signs, but their interpretation depends on the clinical setting. A scan report should not be treated as a stand-alone diagnosis or a reason to dismiss symptoms when characteristic changes are absent. [4, 7]

Other investigations are selected according to the question being asked. Blood tests may look for alternative or additional contributors. Cognitive testing can clarify attention, language, planning, and other functions. A swallowing assessment can identify a safety problem even though it does not diagnose the underlying brain disorder. Some assessments are valuable because they guide care, not because they can settle the diagnostic label. [4]

Dopamine-transporter imaging can provide evidence of certain types of parkinsonism, but it does not reliably distinguish PSP from Parkinson disease by itself. Emerging imaging, blood, and cerebrospinal-fluid biomarkers are important research areas. Their availability or use in a study does not mean they are established diagnostic tests for routine practice. Definitive confirmation of the characteristic PSP brain pathology generally requires examination of tissue after death. [4, 7, 30]

A biomarker is a measurable biological feature, not automatically a useful answer to a clinical question. Researchers need to establish what it measures, how accurately it distinguishes conditions, and whether results are consistent across people and settings. A marker used to track a process in a research group may not yet be suitable for diagnosing an individual. That distinction helps explain why promising testing headlines may precede changes in routine care by years. [23]

Treatment and a coordinated care team

Current treatment focuses on managing symptoms, preventing avoidable complications, supporting participation, and maintaining comfort. No established treatment stops or reverses PSP. This makes coordinated care especially important: the goals of physiotherapy, swallowing support, equipment, medication, and family assistance need to fit together. Improvement in a particular symptom or daily task can still matter even when the underlying condition continues to progress. [5]

Depending on the person’s needs and local services, the team may include a neurologist, primary care clinician, specialist nurse, physiotherapist, occupational therapist, speech and language therapist, dietitian, social worker, and eye-care professional. Palliative care can help with symptoms, communication, and planning at any stage of a serious illness. It can be provided alongside active neurological and rehabilitative care rather than reserved for the final days of life. [5, 18]

A useful care plan connects recommendations to an actual difficulty and a practical goal. Examples include reducing unsafe transfers, making conversation easier, maintaining adequate nutrition, or finding a comfortable seating arrangement. Follow-up matters because benefits, effort, side effects, and feasibility change. Families also need to know who coordinates the plan and which service to contact when a new problem arises or an existing strategy stops working. [5]

Changes that happen abruptly need a fresh assessment. PSP usually progresses over time, so a sudden major decline should not simply be accepted as the next stage. An infection, injury, medicine-related problem, or another acute illness may need attention. The response depends on the symptoms and their severity. A clear plan for routine questions, urgent advice, and emergencies can reduce uncertainty when something changes outside a scheduled appointment. [15]

Medicines and other symptom-focused decisions

A specialist may consider medication for selected movement symptoms, mood changes, sleep problems, or other specific concerns. Levodopa is sometimes tried for stiffness and slowness, although benefit is often limited. Other treatments may target troublesome eyelid closure or excessive saliva. The choice depends on the symptom, likely benefit, existing swallowing and thinking difficulties, and the person’s wider health. These decisions require individual clinical review. [8, 14]

An important distinction is whether a treatment improves a symptom or changes the disease itself. A person may find an intervention helpful without evidence that it slows PSP. Conversely, a plausible biological theory is not enough to establish benefit in daily life. Much of PSP management draws on specialist experience and limited studies, making explicit goals and review of the actual response particularly important. [8]

Medication review should consider the full regimen, including nonprescription products and supplements, because side effects can worsen alertness, constipation, balance, or other difficulties. Swallowing problems can also change which formulations are suitable. Tablets should not be crushed or altered without advice from the prescribing team or pharmacist. A treatment that seemed manageable earlier may need reconsideration as circumstances change; changing or stopping it is a clinical decision. [8, 27]

Supporting safer mobility and everyday life

Physiotherapy can assess walking, posture, movement, transfers, and the support needed for safe activity. Exercise plans should reflect balance, fatigue, cognition, and the home setting. Unsupported exercises copied from a general fitness routine may create avoidable risk. The aim is a workable plan that supports function and participation while acknowledging changing abilities. A therapist can also teach helpers how to assist without placing either person at unnecessary risk. [8, 25]

Walking aids require assessment rather than guesswork. A device that works well for another condition may be unsuitable when backward instability, freezing, visual problems, or impulsivity are prominent. Wheelchairs and other mobility equipment can support access, comfort, and participation when walking becomes unsafe or excessively demanding. Their introduction should be discussed as part of adapting activities and preserving choices, with appropriate fitting and instruction. [8, 10]

Occupational therapy considers how the person and the environment interact. Lighting, clutter, bathroom access, seating, bed height, clothing fastenings, and the layout of frequently used objects can all affect daily effort and safety. A home assessment may identify practical changes or equipment needs. Advice should account for everyone using the space, including the physical limits of carers, rather than assuming that a relative can safely provide unlimited lifting or supervision. [26]

Driving needs specific attention because eye movement, reaction time, judgment, and physical control may change. A person who can still complete some household tasks may nevertheless be unsafe behind the wheel. The clinical team can explain assessment options and the applicable local rules. Planning alternative transport supports appointments and social contact and can reduce the disruption that follows a sudden loss of access to familiar activities. [8, 22]

Adaptation also includes activities that give the day meaning. A hobby may become possible with different materials, a shorter session, a more comfortable position, or help with one part of the task. The relevant question is not simply whether an activity can still be done exactly as before. It is whether a suitable version allows enjoyment, connection, or a sense of contribution without creating an unreasonable burden or safety risk. [18, 26]

Supporting eating, drinking, and communication

A speech and language therapist can assess swallowing and recommend strategies matched to the problem. Assessment may include an instrumental study, such as a videofluoroscopic swallowing study or an endoscopic evaluation, when indicated. Advice can involve positioning, pacing, supervision, and the consistency of food or fluids. Changes should follow an individual assessment: an approach that helps one swallowing pattern may be unsuitable for another. [8, 28]

Nutrition support also considers whether meals are tiring, how long they take, hydration, weight changes, oral health, and the person’s preferences. A dietitian can help assess intake and practical ways of meeting nutritional needs. The care team should review difficulties taking medicines as well as food. Monitoring should lead to a response when a problem emerges, rather than becoming a record of decline without an agreed plan. [8, 9, 28]

A feeding tube may be discussed when eating and drinking no longer meet needs safely or adequately. This is a decision about goals, likely benefits, burdens, and the person’s wishes. A tube may help provide nutrition, fluids, or medicines, but it cannot remove every aspiration risk because saliva or refluxed material can still enter the airway. Decisions benefit from a multidisciplinary discussion and opportunities to revisit questions. [8]

Communication support is equally important. A therapist may suggest speech strategies, writing, picture or letter boards, or electronic communication aids. The method must suit vision, hand control, language, attention, and fatigue, so a complicated device is not automatically the best choice. Introducing options before speech becomes very difficult allows practice and helps preserve the person’s ability to express preferences, report discomfort, and participate in care decisions. [5, 17]

Family support, carers, and planning ahead

PSP can change family roles gradually and then more quickly after a fall, infection, or other complication. Carers may manage appointments, transport, communication, personal care, meals, and overnight needs while also working or caring for others. Their own health, sleep, training, and access to breaks belong in the care plan. Asking what support is sustainable is part of good care, rather than a measure of commitment or affection. [14, 16, 18]

Shared routines and clear communication can reduce some everyday friction. It can help to allow extra time, offer manageable choices, and separate one activity into simpler steps. At the same time, support should preserve adult dignity and the person’s opportunity to decide. Cognitive or speech changes do not automatically remove decision-making ability. The communication method and the specific decision need to be considered before others assume responsibility. [14, 16, 18]

Planning ahead creates space to discuss what matters while communication is easier. Conversations may cover preferred care settings, acceptable assistance, emergency contacts, nutrition decisions, symptom relief, and who should help with decisions if needed. Legal documents and decision-making arrangements vary by jurisdiction. A clinician or appropriate local adviser can explain the options; expressing a preference is useful even when future circumstances cannot be predicted in detail. [21]

Specialist charities, peer groups, social care services, and respite resources can provide practical information and a sense of connection. Availability, eligibility, and costs differ across locations. A workable plan identifies actual services and backup arrangements, rather than simply advising a family to seek support. Review is especially important after changes in mobility, swallowing, communication, living arrangements, or the availability of the main carer. [16, 22]

Care transitions require particular attention. When several services are involved, the people providing help need a consistent understanding of the person’s communication method, current assistance needs, and agreed eating and drinking plan. The person with PSP should remain involved as fully as possible. Clear information can reduce repeated explanations and conflicting advice, while an identified contact makes it easier to resolve a problem rather than leaving the family to coordinate everything alone. [5, 18]

Prognosis, genetics, and research

Outlook and changing care needs

PSP is a progressive, life-limiting illness, but progression varies. The early clinical pattern, complications, and overall health can influence a person’s experience. Population averages cannot provide an individual deadline, and published survival estimates may use different starting points, such as first symptoms or diagnosis. A useful discussion focuses on current function, likely next support needs, and the uncertainty around timing, alongside the person’s own priorities. [2, 13, 15]

Serious complications can include injuries from falls and chest infections related to swallowing difficulties. These risks explain the emphasis on early assessment and ongoing review, without making every complication inevitable. Comfort, meaningful activity, relationships, and supported choices remain valid care goals throughout the illness. Palliative care can help address distressing symptoms and difficult decisions while other professionals continue treatment, rehabilitation, and practical support. [2, 13, 15]

What genetics can and cannot explain

Most PSP occurs sporadically, meaning there is no clear family pattern. Certain common genetic variants are associated with susceptibility, and rare disease-causing changes in the MAPT gene have been reported. A risk-associated variant is different from a mutation that can explain an inherited disorder. Family history, age of onset, and the broader clinical picture may lead a specialist to consider genetic counseling; routine consumer testing cannot settle these questions. [6]

Understanding research claims

Research includes the biology of tau, genetic susceptibility, biomarkers, better ways to measure progression, and possible disease-modifying treatments. A study may test safety or feasibility before it can establish whether a treatment helps. Trial registration, a press release, or an encouraging laboratory result does not demonstrate effectiveness. Participation involves eligibility criteria, informed consent, possible burdens, and uncertainty; a recruiting study may still provide no direct benefit to its participants. [19, 24]

One completed randomized study of the anti-tau antibody gosuranemab illustrates this distinction. It changed a targeted tau measure in cerebrospinal fluid but did not demonstrate clinical efficacy in PSP. This result does not answer every question about tau-directed approaches; it shows why a biological effect and a benefit to patients must be evaluated separately. Research directories can identify studies to discuss with a specialist, while the study team must confirm current eligibility and availability. [20, 24]

Frequently asked questions

Is progressive supranuclear palsy the same as Parkinson disease?

No. PSP and Parkinson disease can both cause slow movement and stiffness, but they have different underlying disease processes and typical clinical patterns. Early falls, vertical eye-movement problems, and limited or short-lived levodopa benefit can suggest PSP. None of these features can establish a diagnosis on its own. [22, 29]

Can a brain scan confirm PSP?

MRI can support the assessment and help identify other causes of symptoms, but no single routine brain scan conclusively confirms PSP in a living person. Specialists interpret imaging alongside the history, examination, and changes over time. Some additional scans are useful for selected questions but do not reliably distinguish PSP from every other parkinsonian disorder. [4, 7]

Is PSP inherited?

Most cases are sporadic, with no clear family history. Common genetic variants can influence susceptibility, and rare inherited cases involving MAPT have been reported. A neurologist or genetic counselor can explain whether a particular family history warrants further assessment. Having a relative with PSP does not mean someone will develop it. [6]

Is there a cure or a treatment that stops PSP?

There is currently no established cure or treatment that stops PSP. Care can address symptoms, communication, mobility, swallowing, nutrition, and comfort. Medicines and other interventions have different possible benefits and burdens, so specialists review them against the person’s goals and changing needs. Experimental treatments require evidence from appropriately conducted studies. [5]

When do swallowing problems need attention?

Coughing with meals, a wet voice after swallowing, longer meals, weight loss, or recurrent chest infections warrant clinical assessment. Aspiration can also occur without obvious coughing. Severe choking or severe difficulty breathing is an emergency. Food or drink modifications should follow professional swallowing advice rather than a general online rule. [8, 9, 12, 28]

How long can someone live with PSP?

There is no reliable individual countdown. PSP is life-limiting, but progression and complications vary, and research averages describe groups rather than a particular person. The clinical team can discuss the current situation, anticipated support needs, and planning while acknowledging uncertainty. Comfort, communication, and quality of life remain important throughout care. [2, 13, 15]

Sources

Numbers in the text refer to the sources below. Official health information and specialist publications serve different purposes; treatment recommendations and research findings should be interpreted in their clinical context.

  1. NINDS: Progressive Supranuclear Palsy National Institute of Neurological Disorders and Stroke; indexed official text checked.
  2. NHS: PSP overview
  3. NHS: PSP symptoms
  4. NHS: PSP diagnosis
  5. NHS: PSP treatment
  6. MedlinePlus Genetics: PSP
  7. Höglinger et al., MDS clinical diagnostic criteria, 2017 Movement Disorder Society clinical diagnostic criteria (2017).
  8. Bluett et al., CurePSP Centers of Care consensus, 2021 CurePSP Centers of Care consensus statement (2021).
  9. NHS: Dysphagia
  10. NHS: Falls
  11. NHS: Head injury and concussion
  12. NHS: Shortness of breath
  13. Mayo Clinic: PSP symptoms and causes Page dated June 6, 2026.
  14. Mayo Clinic: PSP diagnosis and treatment Page dated June 6, 2026.
  15. Johns Hopkins Medicine: PSP
  16. PSP Association: Newly diagnosed with PSP or CBD?
  17. PSP Association: Signs and symptoms
  18. CurePSP: How neuropalliative care can support you and your family Published February 3, 2026.
  19. NIH: Clinical research trials, the basics
  20. Dam et al., gosuranemab randomized trial, 2021 Completed randomized trial (2021); not a current recruitment listing.
  21. NHS: Why plan ahead for end-of-life care?
  22. CurePSP: PSP education
  23. NINDS Parkinson’s Disease Biomarkers Program: Biomarker discovery and validation in PSP Research-project description; does not establish routine diagnostic use or recruitment status.
  24. CurePSP: Research opportunities Eligibility and availability require confirmation with the study team.
  25. NHS: Physiotherapy
  26. NHS: Occupational therapy
  27. NHS: Problems swallowing pills Used for medication-formulation advice; general pill-swallowing exercises are not recommended here.
  28. Communication Health Support Association / ASHA: Swallowing disorders in adults Official ASHA public-information page redirects to this resource.
  29. MedlinePlus Medical Encyclopedia: Progressive supranuclear palsy Reviewed May 4, 2026.
  30. DailyMed: DATSCAN prescribing information, clinical studies section 14.1 Updated April 24, 2026. Used only to clarify that this imaging does not distinguish Parkinson disease, multiple system atrophy, and PSP.

More Sly academy Content

Calculator, pencil, blank practice answer sheet and open notebook beside four subject cards on a bright study desk
AP Score Calculators

PreACT Score Calculator: 2026 Rules & Practice Ranges

Recalculate a PreACT Composite with the correct product and testing-period rules, or check official subject ranges for the identified 2026 PreACT Secure online practice test. Includes worked examples and a focused review plan.

Open »
Calculate Your AP Score
Support Us